Biochem/physiol Actions
β-adrenoceptor agonist; increases cytosolic cAMP.
Features and Benefits
This compound is featured on the β-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Other Notes
For research use only
Packaging
5, 25, 100 g in poly bottle
This product has met the following criteria to qualify for the following awards: